JP2016508506A5 - - Google Patents

Download PDF

Info

Publication number
JP2016508506A5
JP2016508506A5 JP2015556454A JP2015556454A JP2016508506A5 JP 2016508506 A5 JP2016508506 A5 JP 2016508506A5 JP 2015556454 A JP2015556454 A JP 2015556454A JP 2015556454 A JP2015556454 A JP 2015556454A JP 2016508506 A5 JP2016508506 A5 JP 2016508506A5
Authority
JP
Japan
Prior art keywords
group
alkyl
ring
groups
ring member
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015556454A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016508506A (ja
JP6314335B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/051878 external-priority patent/WO2014122067A1/en
Publication of JP2016508506A publication Critical patent/JP2016508506A/ja
Publication of JP2016508506A5 publication Critical patent/JP2016508506A5/ja
Application granted granted Critical
Publication of JP6314335B2 publication Critical patent/JP6314335B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015556454A 2013-02-06 2014-01-31 新しいインダニルオキシジヒドロベンゾフラニル酢酸 Expired - Fee Related JP6314335B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13154261.5 2013-02-06
EP13154261 2013-02-06
PCT/EP2014/051878 WO2014122067A1 (en) 2013-02-06 2014-01-31 New indanyloxydihydrobenzofuranylacetic acids

Publications (3)

Publication Number Publication Date
JP2016508506A JP2016508506A (ja) 2016-03-22
JP2016508506A5 true JP2016508506A5 (enExample) 2017-03-09
JP6314335B2 JP6314335B2 (ja) 2018-04-25

Family

ID=47681765

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015556454A Expired - Fee Related JP6314335B2 (ja) 2013-02-06 2014-01-31 新しいインダニルオキシジヒドロベンゾフラニル酢酸

Country Status (7)

Country Link
US (1) US8927531B2 (enExample)
EP (1) EP2953681B1 (enExample)
JP (1) JP6314335B2 (enExample)
AR (1) AR095163A1 (enExample)
TW (1) TW201518284A (enExample)
UY (1) UY35312A (enExample)
WO (1) WO2014122067A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014372114A1 (en) 2013-11-14 2016-06-09 Cadila Healthcare Limited Novel heterocyclic compounds
CN105566263A (zh) * 2016-01-27 2016-05-11 中国药科大学 一类新型含氮杂环衍生物、其制备方法及其作为药物的用途
JOP20190060A1 (ar) 2016-09-26 2019-03-26 Chugai Pharmaceutical Co Ltd مشتق بيرازولو بيريدين له تأثير مساعد لمستقبل glp-1
JP7461104B2 (ja) * 2017-11-29 2024-04-03 中外製薬株式会社 Glp-1受容体アゴニスト作用を持つピラゾロピリジン誘導体を含有する医薬組成物
WO2019160882A1 (en) 2018-02-13 2019-08-22 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
WO2019204609A1 (en) 2018-04-19 2019-10-24 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
BR112020026746A2 (pt) 2018-07-13 2021-03-30 Gilead Sciences, Inc. Composto, composição farmacêutica, métodos para inibir pd-1, pd-l1 e/ou a interação de pd-1/pd-l1 e para tratar câncer, e, kit para tratar ou prevenir câncer ou uma doença ou condição.
CN112955435B (zh) 2018-10-24 2024-09-06 吉利德科学公司 Pd-1/pd-l1抑制剂
JP2022552655A (ja) 2019-10-07 2022-12-19 キャリーオペ,インク. Gpr119アゴニスト
FI4097099T3 (fi) 2020-02-07 2024-07-30 Gasherbrum Bio Inc Heterosyklisiä glp-1-agonisteja
PH12022552277A1 (en) 2020-02-28 2024-03-04 Kallyope Inc Gpr40 agonists
JP2023526625A (ja) 2020-05-19 2023-06-22 キャリーオペ,インク. Ampkアクチベーター
CN116390925A (zh) 2020-06-26 2023-07-04 卡尔优普公司 Ampk活化剂
AU2024222719A1 (en) 2023-02-16 2025-08-21 Gasherbrum Bio, Inc. Heterocyclic glp-1 agonists

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003277576A1 (en) 2002-11-08 2004-06-07 Takeda Pharmaceutical Company Limited Receptor function controlling agent
JP4594611B2 (ja) * 2002-11-08 2010-12-08 武田薬品工業株式会社 受容体機能調節剤
JP4805552B2 (ja) * 2003-05-30 2011-11-02 武田薬品工業株式会社 縮合環化合物
WO2007033002A1 (en) 2005-09-14 2007-03-22 Amgen Inc. Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
CA2646430A1 (en) * 2006-03-14 2007-09-20 Amgen Inc. Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
ES2379661T3 (es) 2006-06-27 2012-04-30 Takeda Pharmaceutical Company Limited Compuestos cíclicos condensados
MX2010014571A (es) 2008-06-25 2011-03-25 Daiichi Sankyo Co Ltd Compuestos de acido carboxilico.
US20120172351A1 (en) * 2009-06-09 2012-07-05 Nobuyuki Negoro Novel fused cyclic compound and use thereof
HUE025363T2 (en) * 2010-12-01 2016-02-29 Boehringer Ingelheim Int Indanyl Oxide Hydrobenzofuranylacetic Acids that can be used to treat metabolic syndrome
US8809376B2 (en) * 2012-04-30 2014-08-19 Boehringer Ingelheim International Gmbh Indanyloxydihydrobenzofuranylacetic acids

Similar Documents

Publication Publication Date Title
JP2016508506A5 (enExample)
JP2018535963A5 (enExample)
JP2011523412A5 (enExample)
DOP2022000025A (es) Compuestos agonistas de gipr
JP2014511892A5 (enExample)
JP2014511891A5 (enExample)
JP2016515561A5 (enExample)
JP2019524883A5 (enExample)
JP2013519675A5 (enExample)
JP2013542261A5 (enExample)
MX2015001500A (es) Compuestos antidiabeticos triciclicos.
JP2018536648A5 (enExample)
JP2007538024A5 (enExample)
JP2017523226A5 (enExample)
JP2010523476A5 (enExample)
JP2016503797A5 (enExample)
MX2016015182A (es) Compuestos triciclicos antidiabeticos.
CL2021000528A1 (es) Compuestos de 2,6-diaminopiridina
JP2016510326A5 (enExample)
RU2015147447A (ru) Производные доластатина 10 и ауристатинов
JP2020517619A5 (enExample)
JP2015516427A5 (enExample)
JP2016504400A5 (enExample)
JP2019516739A5 (enExample)
JP2015521195A5 (enExample)